Stem-cell cancer treatment developer Vor Biopharma has collected more capital from investors including existing backers Johnson & Johnson and PureTech Health.

Columbia University’s Vor Biopharma has collected more capital from shareholders including Osage University Partners, Johnson & Johnson and PureTech Health.

Reliance's mobile network spinoff has received more than $250m from the chipmaker’s corporate venturing vehicle at a valuation topping $63bn.

The American Express, Comcast and Amazon-backed shopping service is valued at $13.8bn having raised $100m from T.Rowe Price for its latest round.

Celebrity Kim Kardashian West’s beauty brand raised $200m at a $1bn valuation from beauty brand Coty.

The livestreaming broadcaster was valued at more than $600m in a round co-led by investors including Cox Enterprises and Fox Corporation.

The round pushed the overall funding for Stanford's autoimmune and neurodegenerative disorder drug developer past $250m.

The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.

The beauty and cosmetics group is acquiring a 20% stake in Kim Kardashian West's beauty brand at a $1bn valuation in connection with a partnership agreement.

Advancing research from institutions including Harvard, kidney disease-focused Goldfinch Bio now has its sights on clinical trials.